|
|
||||||||||
|
J Am Coll Cardiol, 1999; 33:522-529 © 1999 by the American College of Cardiology Foundation |
a Centro de Investigaciones J.F. Torrealba, Hospital Universitario de Caracas, Centro Médico de Caracas, Caracas, Venezuela
b Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri, USA
Manuscript received February 19, 1998; revised manuscript received August 31, 1998, accepted October 2, 1998.
Reprint requests and correspondence: Julio E. Pérez, MD, Director of Echocardiography, Washington University School of Medicine, 660 S Euclid Avenue, Box 8086, St. Louis, MO 63110-1093
Objectives
To determine whether dobutamine stimulation in patients with Chagas disease may uncover abnormal contractile responses as seen in ischemic myocardium.
Background
Segmental left ventricular (LV) dysfunction in the absence of coronary atherosclerosis is frequently seen in patients with chronic Chagas heart disease. Myocardial ischemia and coronary microcirculation abnormalities have been found in animal models and in humans with Chagas disease. In addition, chagasic sera may contain autoantibodies against human beta-adrenergic receptors.
Methods
Two groups of patients with Chagas disease were studied by echocardiography: group 1 (n = 12) without and group 2 (n = 14) with LV segmental wall motion abnormalities (mostly apical aneurysm). Ten normal subjects served as control subjects. We performed qualitative assessment of wall motion and quantitative evaluation of LV cavity under baseline conditions and after dobutamine stimulation.
Results
Patients with Chagas disease exhibited a blunted inotropic and chronotropic response to dobutamine stimulation. After dobutamine, fractional area change in Chagas group 1 (54.7 ± 6.6%; SD) and in group 2 (35.1 ± 12.1%) were significantly lower than control group (66.7 ± 2.5%; p < 0.001). In addition, in 6 of 14 group 2 patients, dobutamine induced a biphasic response with improvement at low dose and deterioration at peak dose, as seen in patients with coronary artery disease. Although the three groups had similar basal mean heart rates and attained a similar mean peak dobutamine doses, both groups of patients with Chagas disease had a significantly blunted mean heart rate effect after dobutamine (p < 0.0001).
Conclusions
Thus, dobutamine stimulation unmasks a chronotropic incompetence and a blunted myocardial contractile response in chagasic patients, even in those with no overt manifestation of heart disease.
| ||||||||||||
This article has been cited by other articles:
![]() |
H. Acquatella Echocardiography in Chagas Heart Disease Circulation, March 6, 2007; 115(9): 1124 - 1131. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |